Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

1. Bellmunt, J.
2. Hussain, M.
3. Gschwend, J.E.
4. Albers, P.
5. Oudard, S.
6. Castellano, D.
7. Daneshmand, S.
8. Nishiyama, H.
9. Majchrowicz, M.
10. Degaonkar, V.
11. Shi, Y.
12. Mariathasan, S.
13. Grivas, P.
14. Drakaki, A.
15. O'Donnell, P.H.
16. Rosenberg, J.E.
17. Geynisman, D.M.
18. Petrylak, D.P.
19. Hoffman-Censits, J.
20. Bedke, J.
21. Kalebasty, A.R.
22. Zakharia, Y.
23. van der Heijden, M.S.
24. Sternberg, C.N.
25. Davarpanah, N.N.
26. Powles, T.
27. Show all authors +